Vaccines

Always use our prescription products under medical supervision

Brand name

Generic name

Strength

Adacel®

Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Adsorbed

One dose of 0.5ml

Avaxim® 80U/160U

Inactivated Hepatitis A vaccine, Adsorbed I.P

One dose of 0.5ml

FluQuadri®

Quadrivalent Inactivated Influenza Vaccine (Split Virion) I.P

One dose of 0.5ml

Hexaxim®

Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)

One dose of 0.5ml

Imovax® Polio

Poliomyelitis Vaccine (Inactivated) I.P.

One dose of 0.5ml

Menactra®

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

One dose of 0.5ml

Pentaxim®

Adsorbed Diphtheria, Tetanus, Pertussis (Acellular Component), Inactivated Poliomylitis Vaccine and Haemophilus Type B Conjugate Vaccine I.P.

One dose of 0.5ml

Shan5™

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) I.P.

0.5ml, 5ml

Shanchol™

Cholera Vaccine (Inactivated, Oral) I.P.

1.5ml

ShanIPV™

Poliomyelitis vaccine (Inactivated) I.P.

2.5ml ,5ml

ShanTT™

Tetanus Vaccine Adsorbed I.P.

0.5ml, 5ml & 10ml

Shanvac-B®

Hepatitis-B vaccine (r-DNA) I.P.

0.5ml, 1.0ml, 2.0ml , 2.5ml, 3.0ml, 5.0ml & 10ml vials

Stamaril®

Yellow Fever Vaccine (Live)

One dose of 0.5ml

Typhim Vi®

Typhoid Polysachharide Vaccine I.P.

One dose of 0.5ml

Vaxigrip®

Inactivated Influenza vaccine, split virion I.P.

One dose of 0.5ml/0.25ml


Contact for medical information or pharmacovigilance

For reporting adverse events: PV.india@sanofi.com

For medical information (healthcare professionals only):  medinfo.india@sanofi.com

 022-28032000

All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide. A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.

You can email or call us between 9AM and 5PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 1 for medical information and IVRS option 3 for reporting adverse events.